Ensysce Biosciences, Inc. (ENSC)
SEC filings, insider trading & institutional ownership from EDGAR.
Couldn’t find the data you were looking for?
We haven’t added Ensysce Biosciences, Inc.’s filings yet. We add companies and filings all the time.
Track ENSC and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G • latest quarter
| Holder | Filed | Value |
|---|---|---|
| JANE STREET GROUP, LLC | Aug 14, 2026 | $60.56M |
| CITADEL ADVISORS LLC | Sep 1, 2026 | $25M |
| GEODE CAPITAL MANAGEMENT, LLC | Aug 12, 2026 | $18.03M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Aug 14, 2026 | $9.94M |
| UBS Group AG | May 5, 2026 | $4.73M |
ENSC's filings are public. The insight is one click away.
Scrutar's AI reads every ENSC filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Never miss a ENSC filing.
Get an email when ENSC files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Oct 17, 2026Source: SEC EDGAR.